91 related articles for article (PubMed ID: 16118168)
1. MR imaging findings in autoimmune hepatitis: correlation with clinical staging.
Bilaj F; Hyslop WB; Rivero H; Firat Z; Vaidean G; Shrestha R; Woosley JT; Semelka RC
Radiology; 2005 Sep; 236(3):896-902. PubMed ID: 16118168
[TBL] [Abstract][Full Text] [Related]
2. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
[TBL] [Abstract][Full Text] [Related]
3. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease.
Bader TR; Beavers KL; Semelka RC
Radiology; 2003 Mar; 226(3):675-85. PubMed ID: 12616016
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
[TBL] [Abstract][Full Text] [Related]
5. Hepatic sarcoidosis: MR appearances in patients with chronic liver disease.
Ferreira A; Ramalho M; de Campos RO; Heredia V; Roque A; Vaidean G; Semelka RC
Magn Reson Imaging; 2013 Apr; 31(3):432-8. PubMed ID: 23102950
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
7. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
[TBL] [Abstract][Full Text] [Related]
8. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
[TBL] [Abstract][Full Text] [Related]
10. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
11. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging.
Mitchell DG; Navarro VJ; Herrine SK; Bergin D; Parker L; Frangos A; McCue P; Rubin R
Abdom Imaging; 2008; 33(1):58-64. PubMed ID: 17387539
[TBL] [Abstract][Full Text] [Related]
12. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study.
Balassy C; Feier D; Peck-Radosavljevic M; Wrba F; Witoszynskyj S; Kiefer B; Reiter G; Dai Y; Ba-Ssalamah A
Radiology; 2014 Jan; 270(1):149-58. PubMed ID: 23925270
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging.
Zhang XM; Mitchell DG; Shi H; Holland GA; Parker L; Herrine SK; Pasqualin D; Rubin R
AJR Am J Roentgenol; 2002 Aug; 179(2):417-22. PubMed ID: 12130443
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
Lewin M; Vilgrain V; Ozenne V; Lemoine M; Wendum D; Paradis V; Ziol M; Arrivé L; Beaugrand M; Poupon R; Valla D; Chazouillères O; Corpechot C
Hepatology; 2009 Aug; 50(2):528-37. PubMed ID: 19575454
[TBL] [Abstract][Full Text] [Related]
17. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
[TBL] [Abstract][Full Text] [Related]
18. MR imaging findings of early bile duct cancer.
Lee DH; Lee JM; Kim KW; Park HS; Kim SH; Lee JY; Han JK; Choi BI
J Magn Reson Imaging; 2008 Dec; 28(6):1466-75. PubMed ID: 19025934
[TBL] [Abstract][Full Text] [Related]
19. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
Merkle EM; Nour SG; Lewin JS
Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
Choi D; Mitchell DG; Verma SK; Bergin D; Navarro VJ; Malliah AB; McGowan C; Hann HW; Herrine SK
Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
